Yemaachi Biotechnology provides diversifying precision cancer diagnostics and treatments.
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Seed | $3M | 1 | — | — | Detail |
| Aug 31, 2021 | Pre-seed | $425K | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Seed |
|
|
— | Pre-seed |